| ACT | Adoptive cell transfer | 
| AKT | protein kinase B | 
| APCs | Antigen presenting cells | 
| ATP | Adenosine triphosphate | 
| B-ALL | B cell acute lymphoblastic leukemia | 
| Bcl-X(L) | B-cell lymphoma-extra large | 
| CAFs | Cancer-associated fibroblasts | 
| CAR | Chimeric antigen receptor | 
| CAR-M | Chimeric antigen receptor macrophage | 
| CAR-Ps | Chimeric antigen receptors for phagocytosis | 
| CAT | Catalase | 
| CCR | Chimeric costimulatory receptor | 
| CLL | Chronic lymphocytic leukemia | 
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats | 
| CRS | Cytokine release syndrome | 
| ECM | Extracellular matrix | 
| ETBR | Endothelin B receptor | 
| FAO | Fatty acid oxidation | 
| GLUT1 | Glucose transporter 1 | 
| HER2 | Human epidermal growth factor receptor 2 | 
| HK | Hexokinase 2 | 
| HPSE | Heparinase | 
| HSPG | Heparan sulphate proteoglycans | 
| ICOS | Inducible T cell co-stimulator | 
| IDO | Indoleamine-2,3-dioxygenase | 
| IL-10 | Interleukin 10 | 
| LBCL | Large B cell lymphoma | 
| MDSC | Myeloid-derived suppressor cells | 
| MICA | Major histocompatibility complex class I polypeptide-related sequence A | 
| NK | Natural killer | 
| OXPHOS | Oxidative phosphorylation | 
| PD-1 | Programmed cell death protein 1 | 
| PD-L1 | Programmed cell death ligand 1 | 
| PFK-6 | phosphofructo-2-kinase | 
| PGC1-α | PPAR-gamma coactivator 1-α | 
| PGE2 | Prostaglandin E2 | 
| PI3K | Phosphoinositide 3-kinase | 
| PSMA | Prostate-specific membrane | 
| ROS | Reactive oxygen species | 
| ScFv | Single chain variable fragment | 
| TAA | Tumor-associated antigens | 
| TCR | T cell receptor | 
| TGFβ | Transforming growth factor beta | 
| TILs | Tumor-infiltration lymphocytes | 
| TME | Tumor microenvironment | 
| VEGF | Vascular endothelial growth factor |